Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$14.89 USD
+0.21 (1.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $14.87 -0.02 (-0.13%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (91 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.34 | -2.04 | 60.00 |
Year Ago Quarter Estimate | 0.26 | -0.59 | 52.54 |
Next Quarter Estimate | 0.46 | -2.00 | 61.00 |
Next Year Estimate | 2.33 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -2.55 | 10.50 | 17.08 |
Next Year | 21.99 | 13.50 | 8.00 |
Last 5 Years | NA | 5.50 | 8.10 |
Next 5 Years | 10.00 | 22.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.92 | -5.88 |
Price/Book (MRQ) | 4.51 | 1.73 |
Price/Cash Flow (MRFY) | 7.24 | 8.52 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.93% | -19.76% |
Return on Equity (TTM) | 26.56% | -75.03% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.